Compliance: Urine drug testing settlements signal suspicious coding, documentation patterns

Why This Topic Matters

Urine drug testing is a high-enforcement area for billing compliance, and the article highlights pattern-based red flags that auditors, compliance staff, and clinicians should recognize when reviewing claims and documentation.

Article Sections

1. Settlement background and enforcement context

   Introduces recent state and federal settlement activity related to urine drug testing billing and notes that several matters arose from whistleblower allegations. It frames the compliance themes discussed in the rest of the article.

2. Case example: Monos Health

   Summarizes allegations in a Nevada settlement involving same-day testing patterns and related documentation concerns. The section presents the broad compliance issues raised by the case.

3. Case number one: Preferred Pain Management & Spine Care

   Describes allegations involving recurring testing patterns at a North Carolina practice and explains why the reported pattern drew scrutiny. It also discusses broader documentation and medical necessity concerns tied to those allegations.

4. Case number two: Connecticut Addiction Medicine and Nevada Advanced Pain Specialists

   Reviews allegations against two additional practices involving in-office testing and outside laboratory testing relationships. The section focuses on the general documentation and ordering patterns described in the settlements.

5. Resources

   Lists public settlement announcements and related source materials referenced by the article.